You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API ziprasidone mesylate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing ziprasidone mesylate

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Roerig	GEODON	ziprasidone mesylate	0049-1203	BETADEX SULFOBUTYL ETHER SODIUM
Roerig	GEODON	ziprasidone mesylate	0049-1203	METHANESULFONIC ACID
A-S Medication Solutions	GEODON	ziprasidone mesylate	50090-4540	BETADEX SULFOBUTYL ETHER SODIUM
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing ziprasidone mesylate

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-061	BETADEX SULFOBUTYL ETHER SODIUM
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-061	METHANESULFONIC ACID
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-848	BETADEX SULFOBUTYL ETHER SODIUM
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for ziprasidone mesylate

Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM

ziprasidone mesylate drug variants containing BETADEX SULFOBUTYL ETHER SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Roerig	ziprasidone mesylate	0049-1203
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-061
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-848
>Company	>Ingredient	>NDC

ziprasidone mesylate drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
TYA Pharmaceuticals	ziprasidone mesylate	64725-3920
Novadoz Pharmaceuticals LLC	ziprasidone mesylate	72205-205
>Company	>Ingredient	>NDC

Excipient focus: METHANESULFONIC ACID

ziprasidone mesylate drug variants containing METHANESULFONIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Roerig	ziprasidone mesylate	0049-1203
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-061
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-848
>Company	>Ingredient	>NDC

ziprasidone mesylate drug variants not containing METHANESULFONIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SULFOBUTYLETHER .BETA.-CYCLODEXTRIN

ziprasidone mesylate drug variants containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
TYA Pharmaceuticals	ziprasidone mesylate	64725-3920
Novadoz Pharmaceuticals LLC	ziprasidone mesylate	72205-205
>Company	>Ingredient	>NDC

ziprasidone mesylate drug variants not containing SULFOBUTYLETHER .BETA.-CYCLODEXTRIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Roerig	ziprasidone mesylate	0049-1203
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-061
DrReddy's Laboratories Inc	ziprasidone mesylate	43598-848
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.